An Ounce of Prevention
The Centers for Medicare & Medicaid Services (CMS) has issued its 2024 Medicare Physician Fee Schedule (PFS) final rule. Coming in at nearly 3,000 pages, the rule finalizes many significant additions and changes in areas including remote services, care management services, and preventive services. Below we highlightsome of the most notable developments.Prevounce CEO Daniel Tashnek, JD, will explorethese and other takeaways from the final rule during a webinar on Thursday, November 16, at 2:00 PM EST, which you can register for here.
Arthritis is probably one of the most bothersome and frustrating health issues patients face. Classified as both degenerative and chronic, arthritis not only produces pain, but it can also increase symptoms of anxiety and depression, impact independence, contribute to sleep problems, and lead to a host of other chronic health issues due to neglectful self-management of the disorder. Fortunately, patients with the two most common types of arthritis — osteoarthritis and rheumatoid arthritis — are eligible for participation in both chronic care management (CCM) and remote patient monitoring (RPM) services.
The 2024 physician fee schedule (PFS) proposed rule from the Centers for Medicare & Medicaid Services (CMS) had a number of noteworthy proposals. Among them: three potential new care management services intended to help patients, including those with unmet social determinants of health (SDOH) needs and cancer, better navigate and overcome barriers to receiving services and support. These services, which CMS indicated it would pay for separately, are community health integration (CHI), principal illness navigation (PIN), and social determinants of health risk assessments.
The Centers for Medicare & Medicaid Service (CMS) has included numerous proposed changes and additions to remote monitoring and care management in its 2024 physician fee schedule (PFS) proposed rule. We explored the key changes and other important takeaways providers must know about from the proposed rule in a special webinar on July 25 (watch the on-demand recording).
Two Medicare administrative contractors (MACs) that co-hosted a multi-jurisdictional meeting to discuss efficacy of remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM) have announced they will not pursue a local coverage determination (LCD) on RPM and RTM for non-implantable devices.
It's no secret that technology has vastly improved healthcare. In just the past few years, we've seen telehealth essentially transform the delivery of care. From increased access and improved patient outcomes to reductions in care costs, telehealth technology like remote patient monitoring (RPM) is driving healthcare evolution, helping practitioners improve the ways in which we interact with patients every day. Thanks to the ingenuity and creativity of technology thought leaders and innovators, we can now reach more people than ever before, including previously difficult to access rural patients, and do so more effectively and efficiently.